Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Antonio Gidaro

Showing results (1-10 of 82) with videos related to

Pageof 9
Sort By:
Mediterranean Journal of Hematology and Infectious Diseases|July 15, 2016
Bendamustine and Rituximab, as First Line Treatment, in Intermediate, High Risk Splenic Marginal Zone Lymphomas of Elderly PatientsRoberto Castelli, Antonio Gidaro, Giorgio Lambertenghi Deliliers
The Journal of Vascular Access|March 17, 2021
Tunneling technique of PICCs and Midline cathetersDavide Giustivi, Antonio Gidaro, Monica Baroni, et al.
Anti-Cancer Drugs|February 3, 2021
Bendamustine in association with rituximab for first-line treatment of diffuse large B-cell lymphoma in frail patients ineligible for R-CHOP/R-CHOP-like treatmentsRoberto Castelli, Antonio Gidaro, Giorgio L Deliliers, et al.
Anti-Inflammatory & Anti-Allergy Agents in Medicinal Chemistry|August 23, 2021
Concomitant use of Tyrosine-Kinase Inhibitor and Mepolizumab in Asthma Secondary to Chronic Myeloid Leukemia with HypereosinophiliaAntonio Gidaro, Emanuele Salvi, Maria Cristina Carraro, et al.
The Journal of Vascular Access|June 10, 2025
Ultrasound-based tip navigation and tip location during placement of central venous access devices in adult patients: The ECHOTIP protocol revisitedMaria Giuseppina Annetta, Stefano Elli, Antonio Gidaro, et al.
Pharmaceuticals (Basel, Switzerland)|November 27, 2024
Sodium-Glucose Cotransporter-2 Inhibitors in Diabetic Patients with Heart Failure: An UpdateNicia I Profili, Roberto Castelli, Antonio Gidaro, et al.
Clinical Chemistry and Laboratory Medicine|January 27, 2016
Laboratory and clinical risk assessment to treat myelodysplatic syndromesAntonio Gidaro, Giorgio Lambertenghi Deliliers, Paolo Gallipoli, et al.
Journal of Clinical Medicine|November 13, 2021
Prothrombotic and Inflammatory Markers in Elderly Patients with Non-Alcoholic Hepatic Liver Disease before and after Weight Loss: A Pilot StudyAntonio Gidaro, Roberto Manetti, Alessandro Palmerio Delitala, et al.
Anti-Cancer Drugs|August 18, 2021
Risk-tailored treatment of splenic marginal zone lymphomaRoberto Castelli, Monica Balzarotti, Emanuele Salvi, et al.
Anti-Cancer Drugs|August 22, 2015
Salvage therapy with bortezomib and dexamethasone in elderly patients with relapsed/refractory multiple myelomaRoberto Castelli, Giuseppe Pantaleo, Paolo Gallipoli, et al.
Pageof 9

Showing results (1-10 of 82) with videos related to

Sort By:
Pageof 9
Mediterranean Journal of Hematology and Infectious Diseases|July 15, 2016
Bendamustine and Rituximab, as First Line Treatment, in Intermediate, High Risk Splenic Marginal Zone Lymphomas of Elderly PatientsRoberto Castelli, Antonio Gidaro, Giorgio Lambertenghi Deliliers
The Journal of Vascular Access|March 17, 2021
Tunneling technique of PICCs and Midline cathetersDavide Giustivi, Antonio Gidaro, Monica Baroni, et al.
Anti-Cancer Drugs|February 3, 2021
Bendamustine in association with rituximab for first-line treatment of diffuse large B-cell lymphoma in frail patients ineligible for R-CHOP/R-CHOP-like treatmentsRoberto Castelli, Antonio Gidaro, Giorgio L Deliliers, et al.
Anti-Inflammatory & Anti-Allergy Agents in Medicinal Chemistry|August 23, 2021
Concomitant use of Tyrosine-Kinase Inhibitor and Mepolizumab in Asthma Secondary to Chronic Myeloid Leukemia with HypereosinophiliaAntonio Gidaro, Emanuele Salvi, Maria Cristina Carraro, et al.
The Journal of Vascular Access|June 10, 2025
Ultrasound-based tip navigation and tip location during placement of central venous access devices in adult patients: The ECHOTIP protocol revisitedMaria Giuseppina Annetta, Stefano Elli, Antonio Gidaro, et al.
Pharmaceuticals (Basel, Switzerland)|November 27, 2024
Sodium-Glucose Cotransporter-2 Inhibitors in Diabetic Patients with Heart Failure: An UpdateNicia I Profili, Roberto Castelli, Antonio Gidaro, et al.
Clinical Chemistry and Laboratory Medicine|January 27, 2016
Laboratory and clinical risk assessment to treat myelodysplatic syndromesAntonio Gidaro, Giorgio Lambertenghi Deliliers, Paolo Gallipoli, et al.
Journal of Clinical Medicine|November 13, 2021
Prothrombotic and Inflammatory Markers in Elderly Patients with Non-Alcoholic Hepatic Liver Disease before and after Weight Loss: A Pilot StudyAntonio Gidaro, Roberto Manetti, Alessandro Palmerio Delitala, et al.
Anti-Cancer Drugs|August 18, 2021
Risk-tailored treatment of splenic marginal zone lymphomaRoberto Castelli, Monica Balzarotti, Emanuele Salvi, et al.
Anti-Cancer Drugs|August 22, 2015
Salvage therapy with bortezomib and dexamethasone in elderly patients with relapsed/refractory multiple myelomaRoberto Castelli, Giuseppe Pantaleo, Paolo Gallipoli, et al.
Pageof 9